Tyra Biosciences, Inc.
Tyra Biosciences, Inc. (TYRA) — Form SCHEDULE 13D/A: Ownership over 5% (active) (amendment)
About this filing
Tyra Biosciences, Inc. (TYRA) filed Form SCHEDULE 13D/A (ownership over 5% (active) (amendment)) with the SEC on Sep 17, 2026. A Schedule 13D reports an investor owning more than 5% of the company who may seek to influence it.
Key facts
- Document
- —
More TYRA filings
- SC 13G/A
Filed Oct 27, 2026
- SC 13G
Filed Sep 21, 2026
- 4
Filed Sep 17, 2026
- 4
Filed Sep 17, 2026
- 4
Filed Sep 17, 2026
- 4
Filed Sep 17, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.